Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43026 (
lipopolysaccharide
)
62,215
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The involvement of Sp1 in the
lipopolysaccharide
(
LPS
)-induced transcription of HDC mRNA in the mouse macrophage-like cell line RAW 264 was analyzed.
LPS
increased the levels of HDC mRNA 4 h after the stimulation in a concentration-dependent manner. Mithramycin A, an inhibitor of the binding of the Sp family to the GC box, reduced the
LPS
-induced increase in the levels of HDC mRNA at 4 h and
HDC protein
at 8 h in a concentration-dependent manner. By conducting electrophoretic mobility shift assays, we found that one of the transcription factors binding to the DNA probe containing the GC box sequence of the mouse HDC gene promoter region was Sp1, and that levels of Sp1-DNA probe complexes were increased by stimulation with
LPS
although the protein levels of Sp1 were not changed. These results suggested that Sp1 is one of the transcription factors that regulate the
LPS
-induced expression of HDC in RAW 264 cells.
...
PMID:Involvement of Sp1 in lipopolysaccharide-induced expression of HDC mRNA in RAW 264 cells. 1694 47
Roles of mitogen-activated protein (MAP) kinases in
lipopolysaccharide
(
LPS
)-induced production of histamine in the mouse macrophage-like cell line RAW 264 were analyzed. Incubation of RAW 264 cells in the presence of
LPS
increased histamine levels in the conditioned medium in a concentration- and time-dependent manner. The levels of histidine decarboxylase (HDC) mRNA and the 74-kDa
HDC protein
were also increased at 4 to 8 h and 8 to 12 h, respectively.
LPS
elicited the phosphorylation of p44/42 MAP kinase, p38 MAP kinase, and c-Jun N-terminal kinase (JNK). The MAP kinase-Erk kinase 1 inhibitor U0126 (0.1-10 microM) suppressed the
LPS
-induced phosphorylation of p44/42 MAP kinase, and inhibited the
LPS
-induced production of histamine and expression of the HDC mRNA and 74-kDa
HDC protein
in a concentration-dependent manner. The JNK inhibitor SP600125 (3-30 microM) suppressed the
LPS
-induced phosphorylation of c-Jun, and inhibited the
LPS
-induced production of histamine and expression of the HDC mRNA and 74-kDa protein in a concentration-dependent manner. Combined treatment with U0126 (0.3 microM) and SP600125 (10 microM) inhibited the
LPS
-induced production of histamine additively. The p38 MAP kinase inhibitor SB203580 (0.1-10 microM) partially inhibited the
LPS
-induced production of histamine. These findings suggest that
LPS
increases histamine production in RAW 264 cells by inducing the expression of the 74-kDa
HDC protein
, and that the
LPS
-induced expression of HDC is up-regulated at the transcriptional level by MAP kinases, especially p44 MAP kinase and JNK.
...
PMID:Involvement of MAP kinases in lipopolysaccharide-induced histamine production in RAW 264 cells. 1697 63